M&A Deal Summary |
|
|---|---|
| Date | 2010-08-17 |
| Target | Ion Torrent Systems |
| Sector | Information Technology |
| Buyer(s) | Life Technologies |
| Sellers(s) | Bay City Capital |
| Deal Type | Add-on Acquisition |
| Deal Value | 375M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Sector | Test/Measurement Equipment |
| Employees | 10,000 |
| Revenue | 3.8B USD (2012) |
Life Technologies Corporation is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences. With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents and licenses that span the entire biological spectrum – scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research.
| DEAL STATS | # |
|---|---|
| Overall | 13 of 16 |
| Sector (Information Technology) | 3 of 3 |
| Type (Add-on Acquisition) | 10 of 13 |
| State (California) | 7 of 8 |
| Country (United States) | 11 of 13 |
| Year (2010) | 4 of 4 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-04-27 |
Stokes Bio
Limerick, Ireland Stokes Bio Ltd is an Irish company dedicated to the development and application of microfluidic technology, which helps to radically improve and enhance life sciences research and molecular diagnostics. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-07-25 |
Pinpoint Genomics
Mountain View, California, United States Pinpoint Genomics, Inc., and its early-stage non-small cell lung cancer test that can help doctors identify those early-stage patients at high risk for progression to late-stage disease. |
Buy | - |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 31 of 62 |
| Sector (Information Technology) | 2 of 4 |
| Type (Add-on Acquisition) | 17 of 31 |
| State (California) | 14 of 33 |
| Country (United States) | 29 of 59 |
| Year (2010) | 3 of 4 |
| Size (of disclosed) | 6 of 18 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-08-06 |
NuPathe
Malvern, Pennsylvania, United States NuPathe, Inc. is a pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-09-01 |
Dermira
Menlo Park, California, United States Dermira, Inc. is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions. Dermira was founded in 2010 and is based in Menlo Park, California. |
Buy | - |
